These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

550 related articles for article (PubMed ID: 15229889)

  • 1. Calculating proton uptake/release and binding free energy taking into account ionization and conformation changes induced by protein-inhibitor association: application to plasmepsin, cathepsin D and endothiapepsin-pepstatin complexes.
    Alexov E
    Proteins; 2004 Aug; 56(3):572-84. PubMed ID: 15229889
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dissection of the pH dependence of inhibitor binding energetics for an aspartic protease: direct measurement of the protonation states of the catalytic aspartic acid residues.
    Xie D; Gulnik S; Collins L; Gustchina E; Suvorov L; Erickson JW
    Biochemistry; 1997 Dec; 36(51):16166-72. PubMed ID: 9405050
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thermodynamic mapping of the inhibitor site of the aspartic protease endothiapepsin.
    Gómez J; Freire E
    J Mol Biol; 1995 Sep; 252(3):337-50. PubMed ID: 7563055
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Affinity and specificity of serine endopeptidase-protein inhibitor interactions. Empirical free energy calculations based on X-ray crystallographic structures.
    Krystek S; Stouch T; Novotny J
    J Mol Biol; 1993 Dec; 234(3):661-79. PubMed ID: 8254666
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Binding free energies and free energy components from molecular dynamics and Poisson-Boltzmann calculations. Application to amino acid recognition by aspartyl-tRNA synthetase.
    Archontis G; Simonson T; Karplus M
    J Mol Biol; 2001 Feb; 306(2):307-27. PubMed ID: 11237602
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Computational analysis of plasmepsin IV bound to an allophenylnorstatine inhibitor.
    Gutiérrez-de-Terán H; Nervall M; Dunn BM; Clemente JC; Aqvist J
    FEBS Lett; 2006 Oct; 580(25):5910-6. PubMed ID: 17045991
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular dynamics simulations of the three dimensional model of plasmepsin II-peptidic inhibitor complexes.
    Pranav Kumar SK; Kulkarni VM
    Drug Des Discov; 2001; 17(4):293-313. PubMed ID: 11765133
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Very fast prediction and rationalization of pKa values for protein-ligand complexes.
    Bas DC; Rogers DM; Jensen JH
    Proteins; 2008 Nov; 73(3):765-83. PubMed ID: 18498103
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Continuum electrostatic model for the binding of cytochrome c2 to the photosynthetic reaction center from Rhodobacter sphaeroides.
    Miyashita O; Onuchic JN; Okamura MY
    Biochemistry; 2003 Oct; 42(40):11651-60. PubMed ID: 14529275
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Crystal structure of aspartic proteinase from Irpex lacteus in complex with inhibitor pepstatin.
    Fujimoto Z; Fujii Y; Kaneko S; Kobayashi H; Mizuno H
    J Mol Biol; 2004 Aug; 341(5):1227-35. PubMed ID: 15321718
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Free-energy component analysis of 40 protein-DNA complexes: a consensus view on the thermodynamics of binding at the molecular level.
    Jayaram B; McConnell K; Dixit SB; Das A; Beveridge DL
    J Comput Chem; 2002 Jan; 23(1):1-14. PubMed ID: 11913374
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Specific amino acid recognition by aspartyl-tRNA synthetase studied by free energy simulations.
    Archontis G; Simonson T; Moras D; Karplus M
    J Mol Biol; 1998 Feb; 275(5):823-46. PubMed ID: 9480772
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Catalysis and linear free energy relationships in aspartic proteases.
    Bjelic S; Aqvist J
    Biochemistry; 2006 Jun; 45(25):7709-23. PubMed ID: 16784222
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of solvation effects on calculated binding affinity differences: trypsin inhibition by flavonoids as a model system for congeneric series.
    Checa A; Ortiz AR; de Pascual-Teresa B; Gago F
    J Med Chem; 1997 Dec; 40(25):4136-45. PubMed ID: 9406602
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure-based thermodynamic design of peptide ligands: application to peptide inhibitors of the aspartic protease endothiapepsin.
    Luque I; Gómez J; Semo N; Freire E
    Proteins; 1998 Jan; 30(1):74-85. PubMed ID: 9443342
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiple protonation equilibria in electrostatics of protein-protein binding.
    Piłat Z; Antosiewicz JM
    J Phys Chem B; 2008 Nov; 112(47):15074-85. PubMed ID: 18950218
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Energetics of target peptide recognition by calmodulin: a calorimetric study.
    Wintrode PL; Privalov PL
    J Mol Biol; 1997 Mar; 266(5):1050-62. PubMed ID: 9086281
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proton release due to manganese binding and oxidation in modified bacterial reaction centers.
    Kálmán L; Thielges MC; Williams JC; Allen JP
    Biochemistry; 2005 Oct; 44(40):13266-73. PubMed ID: 16201752
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantifying protein microstructure and electrostatic effects on the change in Gibbs free energy of binding in immobilized metal affinity chromatography.
    Pathange LP; Bevan DR; Zhang C
    Anal Chem; 2008 Mar; 80(5):1628-40. PubMed ID: 18229947
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The carboxyl side chain of glutamate 681 interacts with a chloride binding modifier site that allosterically modulates the dimeric conformational state of band 3 (AE1). Implications for the mechanism of anion/proton cotransport.
    Salhany JM; Sloan RL; Cordes KS
    Biochemistry; 2003 Feb; 42(6):1589-602. PubMed ID: 12578372
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.